Bionova Capital is an independent, healthcare-specialized venture capital firm, investing in early-stage life science companies.

Bionova Capital was founded in 2015 and was formerly known as Hovione Capital.

  • Our team has deep expertise in company building and drug development, and a track record investing in therapeutics, medtech and digital health.
  • We invest in Europe, looking for opportunities in academia, biotech, and pharmaceutical companies.
  • We collaborate with exceptional entrepreneurs and provide capital, expertise and access to a global network of resources to add operational, strategic and financial value. We capitalize on our shareholders’ experience, who have successfully built a 60-year-old, profitable business in the global pharmaceutical industry.
  • Before investing in a company, we perform a rigorous and extensive due diligence process and help entrepreneurs improve their product development roadmap.